- The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML)2004 | Second Faculty of Medicine
- Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL2019 | First Faculty of Medicine
- Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network2014 | First Faculty of Medicine
- External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index2022 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine
- Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases2014 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database2014 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial2010 | Third Faculty of Medicine
- Treatment of patients with myelodysplastic syndrome with iron overload oral chelator deferasirox2013 | First Faculty of Medicine
- Current therapeutic approaches in myelodysplastic sydrome2009 | Publication without faculty affiliation
- Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome2021 | Faculty of Medicine in Hradec Králové
- Treatment strategies for myelodysplastic syndrome in 20212021 | Faculty of Medicine in Hradec Králové
- Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma2018 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine
- The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database2018 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents2016 | First Faculty of Medicine
- A high TP53 mutation burden is a strong predictor of primary refractory mantle cell lymphoma2020 | First Faculty of Medicine
- Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial2015 | First Faculty of Medicine
- Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study2022 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Significance of Lymphoma Clinical Registry information potential and limits2004 | Second Faculty of Medicine
- Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial2015 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine
- Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database2017 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine
- Chemoimmunotherapy with ofatumumab in combination with CHOP in previously untreated follicular lymphoma2012 | Faculty of Medicine in Hradec Králové
- Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network2013 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Diffuse large B-cell lymphomas: heterogeneous origin and prognosis from the view of contemporary diagnostics2003 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study2016 | First Faculty of Medicine
- Verification of Survival Predictors in Elderly Patients with Myelodysplastic Syndrome from Outpatient Clinical Practice2018 | First Faculty of Medicine
- Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYA2022 | First Faculty of Medicine
- Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network2016 | Second Faculty of Medicine